EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Management of Severe Abemaciclib-induced Liver Dysfunction: Feasibility of Switching to Palbociclib

Shinya Takada, Kengo Umehara, Kenichi Watanabe

In Vivo · 2026

DOI: 10.21873/invivo.14217 ↗

Kurz gefasst

Fallbericht in der Zeitschrift In Vivo, 2026. Verfasst von Shinya Takada und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan; snowman198019@gmail.com. Hauptthemen laut MEDLINE: Benzimidazoles, Aminopyridines, Piperazines, Pyridines. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BenzimidazolesAminopyridinesPiperazinesPyridinesChemical and Drug Induced Liver InjuryBreast NeoplasmsProtein Kinase InhibitorsHumansFemaleMiddle AgedCyclin-Dependent Kinase 4AgedCyclin-Dependent Kinase 6Antineoplastic Combined Chemotherapy Protocols

Stichwörter der Autor:innen

Breast cancerCDK4/6 inhibitorsabemaciclibdrug-induced liver dysfunctionhepatotoxicitypalbociclib

Substanzen

abemaciclibpalbociclibBenzimidazolesAminopyridinesPiperazinesPyridinesCyclin-Dependent Kinase 4Protein Kinase InhibitorsCyclin-Dependent Kinase 6

Autor:innen und Institutionen

  • Department of Pharmacy, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan; snowman198019@gmail.com.
  • Department of Pharmacy, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan.
  • Department of Breast Surgery, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan.

Zitieren

APA

Takada, S., Umehara, K., & Watanabe, K. (2026). Management of Severe Abemaciclib-induced Liver Dysfunction: Feasibility of Switching to Palbociclib. In Vivo. https://doi.org/10.21873/invivo.14217

Vancouver

Takada S, Umehara K, Watanabe K. Management of Severe Abemaciclib-induced Liver Dysfunction: Feasibility of Switching to Palbociclib. In Vivo. 2026. doi:10.21873/invivo.14217

BibTeX
@article{Takada2026,
  author = {Takada, Shinya and Umehara, Kengo and Watanabe, Kenichi},
  title = {Management of Severe Abemaciclib-induced Liver Dysfunction: Feasibility of Switching to Palbociclib},
  journal = {In Vivo},
  year = {2026},
  doi = {10.21873/invivo.14217}
}
Kostenlos starten →